BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35852402)

  • 1. A novel mutation in the ALS2 gene in an iranian kurdish family with juvenile amyotrophic lateral sclerosis.
    Daneshmandpour Y; Bahmanpour Z; Kazeminasab S; Aghaei Moghadam E; Alehabib E; Chapi M; Tafakhori A; Aghaei N; Darvish H; Emamalizadeh B
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):148-151. PubMed ID: 35852402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
    Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
    Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel splice-site mutation in ALS2 establishes the diagnosis of juvenile amyotrophic lateral sclerosis in a family with early onset anarthria and generalized dystonias.
    Siddiqi S; Foo JN; Vu A; Azim S; Silver DL; Mansoor A; Tay SK; Abbasi S; Hashmi AH; Janjua J; Khalid S; Tai ES; Yeo GW; Khor CC
    PLoS One; 2014; 9(12):e113258. PubMed ID: 25474699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>T.
    Wakil SM; Ramzan K; Abuthuraya R; Hagos S; Al-Dossari H; Al-Omar R; Murad H; Chedrawi A; Al-Hassnan ZN; Finsterer J; Bohlega S
    Gene; 2014 Feb; 536(1):217-20. PubMed ID: 24315819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia.
    Sheerin UM; Schneider SA; Carr L; Deuschl G; Hopfner F; Stamelou M; Wood NW; Bhatia KP
    Neurology; 2014 Mar; 82(12):1065-7. PubMed ID: 24562058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.
    Lai C; Xie C; McCormack SG; Chiang HC; Michalak MK; Lin X; Chandran J; Shim H; Shimoji M; Cookson MR; Huganir RL; Rothstein JD; Price DL; Wong PC; Martin LJ; Zhu JJ; Cai H
    J Neurosci; 2006 Nov; 26(45):11798-806. PubMed ID: 17093100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphisms in uncoding regions of ALS2 gene of Japanese patients with autosomal-recessive amyotrophic lateral sclerosis.
    Nagano I; Murakami T; Shiote M; Manabe Y; Hadano S; Yanagisawa Y; Ikeda JE; Abe K
    Neurol Res; 2003 Jul; 25(5):505-9. PubMed ID: 12866199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
    Hadano S; Kunita R; Otomo A; Suzuki-Utsunomiya K; Ikeda JE
    Neurochem Int; 2007; 51(2-4):74-84. PubMed ID: 17566607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recessive motor neuron diseases: mutations in the ALS2 gene and molecular pathogenesis for the upper motor neurodegeneration].
    Ikeda JE
    Rinsho Shinkeigaku; 2004 Nov; 44(11):792-4. PubMed ID: 15651293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis.
    Hand CK; Devon RS; Gros-Louis F; Rochefort D; Khoris J; Meininger V; Bouchard JP; Camu W; Hayden MR; Rouleau GA
    Arch Neurol; 2003 Dec; 60(12):1768-71. PubMed ID: 14676054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.
    Sato K; Otomo A; Ueda MT; Hiratsuka Y; Suzuki-Utsunomiya K; Sugiyama J; Murakoshi S; Mitsui S; Ono S; Nakagawa S; Shang HF; Hadano S
    J Biol Chem; 2018 Nov; 293(44):17135-17153. PubMed ID: 30224357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS2/alsin knockout mice and motor neuron diseases.
    Cai H; Shim H; Lai C; Xie C; Lin X; Yang WJ; Chandran J
    Neurodegener Dis; 2008; 5(6):359-66. PubMed ID: 18714162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.
    Yang Y; Hentati A; Deng HX; Dabbagh O; Sasaki T; Hirano M; Hung WY; Ouahchi K; Yan J; Azim AC; Cole N; Gascon G; Yagmour A; Ben-Hamida M; Pericak-Vance M; Hentati F; Siddique T
    Nat Genet; 2001 Oct; 29(2):160-5. PubMed ID: 11586297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants.
    Kanekura K; Hashimoto Y; Niikura T; Aiso S; Matsuoka M; Nishimoto I
    J Biol Chem; 2004 Apr; 279(18):19247-56. PubMed ID: 14970233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant.
    Helal M; Mazaheri N; Shalbafan B; Malamiri RA; Dilaver N; Buchert R; Mohammadiasl J; Golchin N; Sedaghat A; Mehrjardi MYV; Haack TB; Riess O; Chung WK; Galehdari H; Shariati G; Maroofian R
    Neurol Sci; 2018 Nov; 39(11):1917-1925. PubMed ID: 30128655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function.
    Panzeri C; De Palma C; Martinuzzi A; Daga A; De Polo G; Bresolin N; Miller CC; Tudor EL; Clementi E; Bassi MT
    Brain; 2006 Jul; 129(Pt 7):1710-9. PubMed ID: 16670179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
    Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
    Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alsin and the molecular pathways of amyotrophic lateral sclerosis.
    Chandran J; Ding J; Cai H
    Mol Neurobiol; 2007 Dec; 36(3):224-31. PubMed ID: 17955197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.
    Hadano S; Hand CK; Osuga H; Yanagisawa Y; Otomo A; Devon RS; Miyamoto N; Showguchi-Miyata J; Okada Y; Singaraja R; Figlewicz DA; Kwiatkowski T; Hosler BA; Sagie T; Skaug J; Nasir J; Brown RH; Scherer SW; Rouleau GA; Hayden MR; Ikeda JE
    Nat Genet; 2001 Oct; 29(2):166-73. PubMed ID: 11586298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.